# Plain Language Summary: Global Fairness in Drug Pricing Act

This bill is designed to bring down prescription drug prices in America by making them more similar to what people pay for the same medications in other wealthy countries like Canada, Germany, and Australia. Right now, Americans often pay significantly more for identical drugs than patients in other developed nations, and this bill aims to fix that problem.

The bill does this in several ways. First, it requires the federal government to create new rules that set price targets for pharmaceutical companies based on what other developed countries pay for the same drugs. The idea is simple: if a blood pressure medication costs $50 in France and $200 in the United States, the government would push the price down closer to the international level. Second, the bill makes it easier for individual Americans to legally import prescription drugs from other developed countries where they're cheaper, as long as it's safe to do so. Third, it tells federal agencies to crack down on pharmaceutical companies if they're using unfair business practices to keep prices artificially high.

The bill also encourages drug manufacturers to sell directly to patients at these lower, internationally-benchmarked prices, cutting out middlemen. Additionally, it requires the government to study whether pharmaceutical companies are unfairly making American patients pay more to subsidize drug development costs that benefit the whole world, or whether they're artificially suppressing prices in foreign markets. For everyday Americans, this could mean significantly lower out-of-pocket costs for medications, though the actual impact would depend on how aggressively the government enforces these new rules and how pharmaceutical companies respond.